These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 7802588)
41. Formation of cyanide after i.v. administration of the oxime HI 6 to dogs. Eyer P; Kawan A; Ladstetter B Arch Toxicol; 1987; 61(1):63-9. PubMed ID: 3439876 [TBL] [Abstract][Full Text] [Related]
42. The efficacy of HI-6 DMS in a sustained infusion against percutaneous VX poisoning in the guinea-pig. Whitmore C; Cook AR; Mann T; Price ME; Emery E; Roughley N; Flint D; Stubbs S; Armstrong SJ; Rice H; Tattersall JEH Toxicol Lett; 2018 Sep; 293():207-215. PubMed ID: 29129798 [TBL] [Abstract][Full Text] [Related]
43. Determination of therapeutic doses of bisquaternary oximes in large animals. Chen R; Raveh L; Zomber G; Rabinovitz I; Cohen G; Adani R; Amitai G J Appl Toxicol; 2001; 21(4):285-91. PubMed ID: 11481661 [TBL] [Abstract][Full Text] [Related]
44. The evaluation of neuroprotective efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats. Kassa J; Karasova J; Vasina L J Appl Toxicol; 2007; 27(6):621-30. PubMed ID: 17685413 [TBL] [Abstract][Full Text] [Related]
45. Protection by a transdermal patch containing physostigmine and procyclidine of soman poisoning in dogs. Kim WS; Cho Y; Kim JC; Huang ZZ; Park SH; Choi EK; Shin S; Nam SY; Kang JK; Hwang SY; Kim YB Eur J Pharmacol; 2005 Nov; 525(1-3):135-42. PubMed ID: 16256978 [TBL] [Abstract][Full Text] [Related]
46. Superior efficacy of HI-6 dimethanesulfonate over pralidoxime methylsulfate against Russian VX poisoning in cynomolgus monkeys (Macaca fascicularis). Reymond C; Jaffré N; Taudon N; Menneteau M; Chaussard H; Denis J; Castellarin C; Dhote F; Dorandeu F Toxicology; 2018 Dec; 410():96-105. PubMed ID: 30218682 [TBL] [Abstract][Full Text] [Related]
47. HI-6 and 2-PAM in sheep: pharmacokinetics and effects on muscle tissue following intramuscular injection. Moore DH; Hayward IJ; Tucker FS; Lukey B Biopharm Drug Dispos; 1991 Apr; 12(3):223-32. PubMed ID: 2059672 [TBL] [Abstract][Full Text] [Related]
48. HI-6 oxime (an acetylcholinesterase reactivator): blood plasma pharmacokinetics and organ distribution in experimental pigs. Kuneš M; Květina J; Bureš J; Karasová JZ; Pavlík M; Tachecí I; Musílek K; Kuca K Neuro Endocrinol Lett; 2014; 35 Suppl 2():191-6. PubMed ID: 25638385 [TBL] [Abstract][Full Text] [Related]
49. Effect of pyridostigmine pretreatment, HI-6 and Toxogonin treatment on rat tracheal smooth muscle response to cholinergic stimulation after organophosphorus inhalation exposure. Walday P; Aas P; Haider T; Fonnum F Arch Toxicol; 1993; 67(3):212-9. PubMed ID: 8494501 [TBL] [Abstract][Full Text] [Related]
50. Effect of pyridostigmine pretreatment on cardiorespiratory function in tabun poisoning. Worek F; Kleine A; Szinicz L Hum Exp Toxicol; 1995 Aug; 14(8):634-42. PubMed ID: 7576830 [TBL] [Abstract][Full Text] [Related]
51. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Antonijevic B; Stojiljkovic MP Clin Med Res; 2007 Mar; 5(1):71-82. PubMed ID: 17456837 [TBL] [Abstract][Full Text] [Related]
52. Disposition of HI-6 oxime in rats after intravenous and intramuscular administration. Simons KJ; Briggs CJ J Pharm Pharmacol; 1985 May; 37(5):367-9. PubMed ID: 2862253 [TBL] [Abstract][Full Text] [Related]
53. Effect of atropine and the oxime HI-6 on low-level sarin-induced alteration of performance of rats in a T-maze. Krejcová G; Kassa J; Vachek J Acta Medica (Hradec Kralove); 2002; 45(3):107-10. PubMed ID: 12515047 [TBL] [Abstract][Full Text] [Related]
54. Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics. Worek F; Koller M; Thiermann H; Wille T Toxicology; 2016 Mar; 350-352():25-30. PubMed ID: 27153754 [TBL] [Abstract][Full Text] [Related]
55. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice. Kassa J; Sepsova V; Matouskova L; Horova A; Musilek K Toxicol Mech Methods; 2015 Mar; 25(3):229-33. PubMed ID: 25894563 [TBL] [Abstract][Full Text] [Related]
56. Assessing the therapeutic efficacy of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig. Snider TH; Wilhelm CM; Babin MC; Platoff GE; Yeung DT J Toxicol Sci; 2015 Dec; 40(6):759-75. PubMed ID: 26558457 [TBL] [Abstract][Full Text] [Related]
57. Hyaluronidase: its effects on HI-6 dichloride and dimethanesulphonate pharmacokinetic profile in pigs. Karasova JZ; Pavlik M; Chladek J; Jun D; Kuca K Toxicol Lett; 2013 Jul; 220(2):167-71. PubMed ID: 23624064 [TBL] [Abstract][Full Text] [Related]
58. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro. Worek F; Aurbek N; Thiermann H J Appl Toxicol; 2007; 27(6):582-8. PubMed ID: 17370251 [TBL] [Abstract][Full Text] [Related]
59. Behavioral, Pharmacokinetic, and Cardiovascular Evaluation of Candidate Oximes in African Green Monkeys. Moffett MC; McDonough JH; McMonagle JD; Myers TM Int J Toxicol; 2018; 37(5):352-363. PubMed ID: 29879849 [TBL] [Abstract][Full Text] [Related]
60. Oral forms of the oxime HI-6: a study of pharmacokinetics and tolerance after administration to healthy volunteers. Jovanovic D; Maksimovic M; Joksovic D; Kovacevic V Vet Hum Toxicol; 1990 Oct; 32(5):419-21. PubMed ID: 2238436 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]